These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20142468)

  • 1. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
    Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
    J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesions of the corpus callosum in children with neurofibromatosis 1.
    Mimouni-Bloch A; Kornreich L; Kaadan W; Steinberg T; Shuper A
    Pediatr Neurol; 2008 Jun; 38(6):406-10. PubMed ID: 18486822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational age at preterm birth in relation to corpus callosum and general cognitive outcome in adolescents.
    Narberhaus A; Segarra D; Caldú X; Giménez M; Junqué C; Pueyo R; Botet F
    J Child Neurol; 2007 Jun; 22(6):761-5. PubMed ID: 17641266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
    Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
    J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-tensor imaging derived metrics of the corpus callosum in children with neurofibromatosis type I.
    Filippi CG; Watts R; Duy LA; Cauley KA
    AJR Am J Roentgenol; 2013 Jan; 200(1):44-9. PubMed ID: 23255740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interhemispheric transfer in children with heavy prenatal alcohol exposure.
    Roebuck TM; Mattson SN; Riley EP
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1863-71. PubMed ID: 12500111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning.
    Schatz J; Buzan R
    J Int Neuropsychol Soc; 2006 Jan; 12(1):24-33. PubMed ID: 16433941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive profile of preschool-aged children with neurofibromatosis type 1.
    Sangster J; Shores EA; Watt S; North KN
    Child Neuropsychol; 2011; 17(1):1-16. PubMed ID: 20503125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].
    Trzcińska M; Borkowska A
    Psychiatr Pol; 2005; 39(2):371-81. PubMed ID: 15881631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus callosum size in children with spastic cerebral palsy: relationship to clinical outcome.
    Kułak W; Sobaniec W; Kubas B; Walecki J
    J Child Neurol; 2007 Apr; 22(4):371-4. PubMed ID: 17621513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status.
    Moore BD; Slopis JM; Jackson EF; De Winter AE; Leeds NE
    Neurology; 2000 Feb; 54(4):914-20. PubMed ID: 10690986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of corpus callosal morphometry with cognitive and motor function in periventricular leukomalacia.
    Davatzikos C; Barzi A; Lawrie T; Hoon AH; Melhem ER
    Neuropediatrics; 2003 Jun; 34(5):247-52. PubMed ID: 14598230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velazquez-Fragua R; Viaño J
    Rev Neurol; 2012 Nov; 55(9):528-32. PubMed ID: 23111991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in neurofibromatosis type 1.
    Ozonoff S
    Am J Med Genet; 1999 Mar; 89(1):45-52. PubMed ID: 10469436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.
    Pascual-Castroviejo I; Pascual-Pascual SI
    Childs Nerv Syst; 2012 Dec; 28(12):2177-80. PubMed ID: 23001021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive control in adolescents with neurofibromatosis type 1.
    Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
    Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.